{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:21:56Z","timestamp":1760887316774,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1124\/dmd.31.8.1049","type":"journal-article","created":{"date-parts":[[2003,7,16]],"date-time":"2003-07-16T20:26:32Z","timestamp":1058387192000},"page":"1049-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["ROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF (\u2013)-VERBENONE BY LIVER MICROSOMES"],"prefix":"10.1016","volume":"31","author":[{"given":"Mitsuo","family":"Miyazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.31.8.1049_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/PL00000709","article-title":"Molecular modeling of mammalian cytochrome P450s.","volume":"57","author":"Dai","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/dmd.31.8.1049_bib2","first-page":"15","article-title":"Chemical composition and antimicrobial activity of Rosemarinus officinalis L. oil from Sardinia and Corsica.","volume":"17","author":"Giorgio","year":"2002","journal-title":"Folia Pharmacol Jpn"},{"key":"10.1124\/dmd.31.8.1049_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(90)90006-N","article-title":"Molecular genetics of the P-450 superfamily.","volume":"45","author":"Gonzalez","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.31.8.1049_bib4","series-title":"Principles and Methods of Toxicology","first-page":"1259","article-title":"Analysis and characterization of enzymes","author":"Guengerich","year":"1994"},{"key":"10.1124\/dmd.31.8.1049_bib5","first-page":"701","article-title":"(R)-(+) Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6.","volume":"26","author":"Khojasteh-Bakht","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.8.1049_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-199302000-00001","article-title":"Predicting the cytochrome P450 mediated metabolism of xenobiotics.","volume":"3","author":"Korzekwa","year":"1993","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.31.8.1049_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/004982598239236","article-title":"The CYP2 family: models, mutants and interactions.","volume":"28","author":"Lewis","year":"1998","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.31.8.1049_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent.","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.31.8.1049_bib9","first-page":"200","article-title":"Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from Eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.","volume":"29","author":"Miyazawa","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.8.1049_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/00498250110065595","article-title":"Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, the monoterpene cyclic ether, by rat and human liver microsomes.","volume":"31","author":"Miyazawa","year":"2001","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.31.8.1049_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/tx0155350","article-title":"Sex differences in the metabolism of (+)- and (\u2013)-limonene enantiomers to carveol and perillyl alcohol derivatives by cytochrome P450 enzymes in rat liver microsomes.","volume":"15","author":"Miyazawa","year":"2002","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.31.8.1049_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/dmd.30.5.602","article-title":"Metabolism of (+)- and (\u2013)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.","volume":"30","author":"Miyazawa","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.8.1049_bib13","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1271\/bbb.66.2458","article-title":"Biotransformation of (\u2013)-verbenone by human liver microsomes.","volume":"66","author":"Miyazawa","year":"2002","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1124\/dmd.31.8.1049_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1146\/annurev.bi.56.070187.004501","article-title":"P450 genes: structure, evolution and regulation.","volume":"56","author":"Nebert","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/dmd.31.8.1049_bib15","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature.","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.31.8.1049_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0300-483X(99)00200-0","article-title":"CYP2A6: a human coumarin 7-hydroxylase.","volume":"144","author":"Pelkonen","year":"2000","journal-title":"Toxicology"},{"key":"10.1124\/dmd.31.8.1049_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/dmd.30.5.525","article-title":"Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism.","volume":"30","author":"Rae","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.8.1049_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1099-1026(199703)12:2<109::AID-FFJ618>3.0.CO;2-A","article-title":"Identification of (1R)(+)verbenone in essential oils of Rosmarinus officinalis L.","volume":"12","author":"Ravid","year":"1997","journal-title":"Flavour Fragr J"},{"key":"10.1124\/dmd.31.8.1049_bib19","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/carcin\/23.7.1199","article-title":"Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL\/6J mice.","volume":"23","author":"Shimada","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.31.8.1049_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2133\/dmpk.17.507","article-title":"Species differences in the metabolism of (+)and (\u2013)-limonenes and their metabolites, carveols and carvones, by cytochrome P450 enzymes in liver microsomes of mice, rats, guinea pigs, henoba, dogs, monkeys and humans.","volume":"17","author":"Shimada","year":"2002","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.31.8.1049_bib21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0090-9556(24)14929-X","article-title":"Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone using kinetic parameters of recombinant cytochrome P450 enzymes.","volume":"27","author":"Shimada","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.8.1049_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.8.1049_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-9861(80)90274-X","article-title":"Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver.","volume":"199","author":"Wang","year":"1980","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.31.8.1049_bib24","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/0006-2952(94)90579-7","article-title":"Catalytic roles of rat and human cytochrome P450 2A enzymes in testosterone 7\u03b1- and coumarin 7-hydroxylations.","volume":"48","author":"Yamazaki","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.31.8.1049_bib25","first-page":"679","article-title":"Purification and characterization of human liver microsomal cytochrome P-450 2A6.","volume":"40","author":"Yun","year":"1991","journal-title":"Mol Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624027430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624027430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.31.8.1049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:12:00Z","timestamp":1739891520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624027430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0090955624027430"],"URL":"https:\/\/doi.org\/10.1124\/dmd.31.8.1049","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2003,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF (\u2013)-VERBENONE BY LIVER MICROSOMES","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.31.8.1049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}